San Francisco, CA -- The American Federation for Aging Research (AFAR), http://www.afar.org, the world-renowned non-profit organization dedicated to supporting and advancing healthy aging through biomedical research, will host a luncheon symposium on biotechnology and longevity on Tuesday, July 25, 2017 from 12 noon to 3:00 p.m. at the Westin St. Francis San Francisco on Union Square.

- Principal Investigator of the Targeting Aging with Metformin (TAME) Trial AFAR Deputy Scientific Director and Director of the Institute for Aging Research, Albert Einstein College of Medicine

Judith Campisi, Ph.D. - Scientific Co-Founder of Unity Biotechnology and former member of the Scientific Advisory Board of Sangamo Biosciences Professor, Buck Institute for Research on Aging

Nathaniel David, Ph.D. - President of Unity Biotechnology

Jan van Deursen, Ph.D. - Co-founder of Unity Biotechnology Director of the Senescence Program in the Robert and Arlene Kogod Center on Aging, Mayo Clinic

President and Chief Executive Officer, Buck Institute for Research on Aging

The text above is a summary, you can read full article here.